Objective: This review was conducted to evaluate the types of endovascular procedures that can be performed via brachial artery access, evaluate the access success rate, and determine the incidence of technical complications.
Peripheral vascular disease (PVD) is a major cause of morbidity in an ever-increasing population of patients with diabetes, chronic kidney disease, and smokers. 1 Endovascular access for treatment of PVD is typically performed through a common femoral artery (CFA) puncture. [2] [3] [4] Relative contraindications to CFA puncture include absent femoral pulses, recent intervention to the femoral artery, severe aortoiliac-femoral occlusive disease, femoral aneurysms or pseudoaneurysm, groin hematomas, and the presence of a bypass graft. [5] [6] [7] [8] [9] A reliable alternative access site is a necessity for a complete array of endovascular strategies.
Approaches to arterial access through locations other than the CFA include axillary, brachial, radial, and ulnar arteries, as well as the translumbar approach. 5, [8] [9] [10] [11] [12] The brachial artery (BA) and radial artery (RA) have received attention in the cardiac literature but seemingly less attention for peripheral interventions. [9] [10] [11] [12] [13] [14] Although some distal lesions may be out of reach from a BA approach, the advent of new longer catheters and wires have brought many of these lesions within reach. The goal of this 10-year retrospective review was to evaluate our experience with BA access for peripheral interventions.
METHODS
Our technique for percutaneous BA access begins with the sterilely prepared patient placed supine with the access arm extended on a radiolucent arm board. The overlying skin is anesthetized, and the BA is accessed with a 21-gauge micropuncture needle under ultrasound guidance. The BA is accessed distally on the humerus, proximal to the olecranon fossa, to ensure a boney surface to compress the vessel postoperatively, and ultrasound guidance confirms a location proximal to the radial-ulnar bifurcation. A 4F microsheath (Cook, Inc, Bloomington, Ind) is inserted over a guidewire. A Cobra The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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http://dx.doi.org/10.1016/j.jvs.2017.01.050 2 or Contra 2 catheter (Boston Scientific, Minneapolis, Minn) is used to obtain access of the descending aorta and a 260-cm J wire is navigated into the abdominal aorta. A 4F Â 90-cm sheath (Cook, Inc) is inserted over the J wire into the abdominal aorta, allowing a rapid exchange of catheters and wires with minimal arch manipulation. If an intervention is performed, the sheath is upsized appropriately. An access site arteriogram is taken before upsizing the sheath to ensure adequate arterial size to accommodate a larger sheath. If vasospasm has occurred, papaverine (120 mg/250 mL normal saline) or nitroglycerine (50 mg/mL), or both, are injected as needed. An access site angiogram is performed at the conclusion to assess the access site for vessel spasm, distal blood flow, and the presence of thrombus before sheath removal.
After sheath removal, direct digital pressure is applied for a minimum of 20 minutes by a dedicated "hold nurse" to achieve hemostasis. The patient is instructed to keep the access arm straight for 6 hours. The dedicated hold nurse has had experience in CFA access holds before being graduated to holding BA access sites. The experience of each nurse is documented and internally verified to ensure the nurse has an appropriate experience level to hold a BA access site. An Institutional Review Board-approved, retrospective record review at a tertiary care facility from January 1, 2005, through June 30, 2015 was performed, with patient consent waived. A search was conducted for all patients who underwent percutaneous arterial puncture and access to the upper extremity using Current Procedural Terminology (American Medical Association, Chicago, Ill) code 36120 for the procedure and by searching the operating room schedule for cases scheduled as upper extremity access. All medical records of patients who underwent BA access during the study interval were reviewed. A total of 265 procedures were performed on 179 patients. All patients included in the study underwent peripheral angiography, with or without intervention through percutaneous BA access.
The intent of this review was to evaluate the ability to access the BA successfully with the intention to treat peripheral vascular lesions through the BA access and describe the incidence of complications in order to clarify the utility and safety of BA access. The variables analyzed included patient demographics (gender, age, ethnicity, smoking history, and diabetic status), procedure performed, laterality of access, maximal sheath size, peripheral arterial locations treated, complications (bleeding, hematoma, pseudoaneurysm, thrombosis, dissection, arteriovenous fistula, neurologic deficit, inability to reach diseased segment secondary to catheter length, and failure to successfully cannulate the vessel), and indications for the procedure. Descriptive statistics for the above variables were reported.
RESULTS
Demographic data of the patient population and indications for the procedure were collected and are outlined in Table I . Most cases were performed for PVD (87.9%), and 53.2% of patients had a bypass graft (aortobifemoral, femoral-popliteal, or femoral-femoral). Subclavian steal, stenosis of carotid-subclavian bypass graft, or upper extremity disease was the indication in 25 procedures (9.4%).
Success rate for access was 98.9% (262 of 265), with only three access attempts failing in two different patients. The three failed access attempts involved dissection planes created on access. Both patients were each successfully accessed in the same vessel at a later date. No patients scheduled for BA access were abandoned based on ultrasound findings. The left BA was preferentially accessed (245 cases [92.5%]), and the right BA was accessed in 20 cases in 11 different patients and chosen for patients with right upper extremity disease or preference to not have the left arm accessed. The BA was accessed more than once in 50 of the 179 patients (27.9%). Sheath size ranged from 4F to 7F, with at least a 5F sheath used for most interventions. A variety of procedures were performed, as detailed in Fig. Diagnostic angiography alone was performed in 39 cases (14.9%). The most commonly performed procedure was balloon angioplasty (154 [58.8%]). Of the 265 cases, 220 (83%) involved intervention to the lower extremities for PVD where bilateral lesions could have been encountered, and 38 of these cases (14.5%) included intervention to both right and left lower extremity lesions through a solitary BA puncture without the need for a second access site. Interventions were performed on vessels as distal as the dorsalis pedis artery. The arterial regions treated are listed and categorized into groups in Table II . In only six cases (2.7%) could the target lesion not be reached owing to catheter length limitations.
Complications were evaluated as outlined in Table III . No significant events of postprocedural bleeding, arterial thrombosis, or median nerve injury were documented, and no limb loss occurred. One patient had persistent bleeding from the skin at the puncture site that was adequately repaired with a suture in the recovery area. 
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DISCUSSION
After evaluating data over a 10-year period, we noted an overall successful access rate of 98.9%, similar to other reported data. [2] [3] [4] [5] 13 Failure of access can be attributed to multiple prior procedures on the artery, arterial spasm, and arterial dissection. 7 BA access offers a full range of interventions to all clinically relevant arterial regions. The development of longer catheters and wires has led to the ability to treat more distal lesions through BA access. Catheter length is a concern for upper extremity access techniques, with lesions distal to the iliofemoral region potentially being out of reach. The advent of longer wires, catheters, and sheaths, has made distal lesions more approachable through upper extremity access.
Complications exist with all arterial access. Overall complication rates as high as 36% have been reported for BA access, and major complications (pseudoaneurysm, arteriovenous fistula, thrombosis, hematoma, permanent neurologic deficit, and dissection) as high as 7% to 11% have been reported. 5 ,6,8, 13 The most frequent major Unable to reach lesion 6 (2.7)
complication is the development of a pseudoaneurysm, which has been reported in 0.6% to 6% of patients. 5, 6 The pseudoaneurysm incidence in our cohort was 1.6%. Minor complications include ecchymosis, soreness, vasovagal reaction, temporary loss of distal pulses, and temporary paresthesias. 7, 13 Recent studies have shown that BA access can be a safe and effective alternative to femoral access, with complication rates of between 1.3% and 3.4% reported. 2, 3, 10, 14 The complication rate in our patients requiring intervention or admission was 1.9%. Our low complication rate can be attributed to the routine use of ultrasound guidance, 4F micropuncture kits, and dedicated hold team nurses who are specially trained to hold BA access sites. Use of ultrasound guidance and smaller-sized micropuncture kits is commonplace for vascular access. Unique to our experience is a dedicated hold team of nurses and radiology technicians who are observed by experienced nurses and practitioners while holding femoral access sites until they are credentialed to hold femoral access sites independently. Those who have met our internal standards for holding femoral access sites independently are similarly proctored to hold BA sites. After they have been observed holding multiple BA access sites, they are graduated to care for BA access sites independently. We attribute this gradual experience, internal proctoring, and verification system as being a significant component to our low complication rate.
Vascular closure devices (VCDs) are not used at our facility for BA hemostasis. Closure devices are being extensively reviewed, and many studies indicate they are safe and do not increase complication rates in femoral closure. [15] [16] [17] [18] Currently, no VCDs are indicated for use in the BA; however, early reports from studies that have reviewed off-label use of VCDs in the BA indicate they are likely safe. 19, 20 Further studies evaluating the use and safety of VCDs in BA access should be completed. Our report demonstrates the ability to intervene on bilateral lesions via BA access. Of the described 265 cases, 220 were performed on patients with PVD who could have required intervention to lesions in both extremities. A solitary BA access was used for bilateral lower extremity interventions in 38 cases (14.5%). There were no instances of bilateral disease where one side was unable to be approached through the BA or required a second arterial access to approach either side. This is especially advantageous for patients with known bilateral disease. A single procedure through one access site to treat bilateral lesions could potentially save a patient from an additional intervention or a second access site. In addition, 53.2% of the patients reviewed had a bypass graft at the CFA. The ability to avoid arterial puncture at a graft site decreases the risk of graft thrombosis and infection, and avoiding access in a hostile groin is advantageous. Patients with a previous endovascular aortic aneurysm repair should especially be considered for upper extremity access, because navigating the flow divider from retrograde access may be impossible. BA access allows for earlier ambulation compared with femoral access. Earlier mobilization improves patient comfort, making angiography more tolerable for patients with comorbidities such as chronic back pain, congestive heart failure, or obesity. 6, 13 Although our review did not report length of stay, future studies may be able to demonstrate that routine use of BA access may decrease postoperative length of stay and improve patient satisfaction. RA access provides the above listed advantages of BA access and has been adopted for routine use in coronary angiography. The RA is not an end artery, and the ulnar artery provides dominant flow in most individuals, making consequences from RA access less likely to be devastating. However, RA access continues to be limited in use for treatment of PVD because of the distance from the RA to infrainguinal regions. Most of our interventions involved infrainguinal arteries that would have been out of reach for RA access techniques. As technology advances, RA access may have more of a roll in treatment of PVD.
This review has several limitations. First, this a retrospective, nonrandomized study. The choice of using BA access was by surgeon preference and chosen after discussing the access site options with the patient. The BA was chosen in most patients because of an existing graft in the femoral region, multiple prior access site attempts to the femoral artery, or an otherwise hostile groin. A formal protocol for choosing BA access rather than femoral access will help identify the optimal patient for BA access and allow direct comparisons among similar groups of patients undergoing BA vs femoral artery access. A second limitation is in identifying postoperative complications. Different interpretations and documentation related to postoperative bleeding and hematomas could have varied, and subclinical bleeding that did not require transfusion and small hematomas could have been overlooked. We evaluated our access complications primarily on postoperative day 1, and our patients are routinely seen in the office 2 to 4 weeks postoperatively. Documentation of the access site in postoperative office varies, but our standard practice is to evaluate any suspected access site complication with duplex ultrasound imaging.
The only injuries to the BA identified during follow-up were in the pseudoaneurysm group. Three of the four were identified during outpatient follow-up #4 weeks of access as a pulsatile mass and were repaired in an urgent matter. The fourth pseudoaneurysm was identified before the patient was discharged and required a vein patch angioplasty. The remainder of the cohort was not identified as having a complication during follow-up.
Vessel patency was not routinely evaluated postoperatively with ultrasound imaging, but no patients were identified clinically as having significant flow limitation manifesting as effort-induced claudication or pulse discrepancies, and no patients developed signs of ischemia.
Our standard practice is to obtain ultrasound imaging on any patient with clinically suspicious findings concerning for decreased vessel patency. In the future, obtaining routine ultrasound surveillance of the access site and distal vessels to assure adequate patency may be considered.
Another limitation is a lack of a comparison group in which CFA access was used. However, because CFA access is the standard technique and complication rates are well documented, the use of general population data for CFA access to compare to our BA access complication rate is reasonable. In a review of vascular complications after CFA access for coronary intervention, 6.1% of patients developed a complication (hematoma, bleeding, fistula formation, pseudoaneurysm, or the need for surgical repair), and 2.3% required vascular repair. 21 Our overall complication rate of 3.8%, with 1.9% requiring intervention, is certainly comparable to standard CFA access; however, further studies of BA access should be compared with a matched control group of CFA access.
CONCLUSIONS
Our 10-year review of BA access at a tertiary care facility demonstrated that BA access is a safe and reliable alternative to femoral artery access for peripheral arterial intervention. BA access offers a wide variety of endovascular interventions in every major peripheral arterial region. Catheter length limitations have become less of a problem because longer catheters, wires, and sheaths have been developed. Future prospective and randomized studies could be completed comparing routine BA access to femoral access to further define the optimal patient population who would benefit from primary BA access. 
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